Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Indian J Surg ; 82(3): 284-285, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-1920084
3.
J Clin Psychol Med Settings ; 29(1): 150-161, 2022 03.
Article in English | MEDLINE | ID: covidwho-1248737

ABSTRACT

With the advent of the novel coronavirus (COVID-19) pandemic, health-care workers have been faced with an inordinately high level of trauma as frontline providers. The Medical College of Wisconsin (MCW) partnered with affiliate hospitals and community partners to mobilize a matrix of available support and interventions to deliver psychological services to reach all levels of health-care providers in timely, accessible formats. While virtual peer support groups were the most utilized resource among the support group options, other opportunities also provided unique benefits to learners whose education had been disrupted by the pandemic. Mental health must be prioritized for health-care workers in the event of future public health crises. Lessons learned from this pandemic indicate that it is critical to involve learners early on in the process in order to meet their educational needs and to increase access to evidence-based care.


Subject(s)
COVID-19 , Pandemics , Health Personnel/psychology , Humans , Mental Health , Wisconsin
4.
Malays J Med Sci ; 27(6): 187-189, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-1032676

ABSTRACT

Breast complaints are a very common cause of healthcare visits in the female population. They range in severity from benign to malignant, and treatment options vary from simple observation to mastectomy. As healthcare facilities are overburdened with coronavirus disease 2019 (COVID-19) patients, properly triaging patients diagnosed with breast disorders is necessary for the optimal use of limited resources in developing countries. We are proposing a concise triage system for timely intervention among patients with breast disorders during the havoc of the COVID-19 pandemic.

5.
Stem Cell Rev Rep ; 17(1): 94-112, 2021 02.
Article in English | MEDLINE | ID: covidwho-841111

ABSTRACT

Coronavirus disease 2019 (COVID-19) is caused by novel coronavirus Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first time reported in December 2019 in Wuhan, China and thereafter quickly spread across the globe. Till September 19, 2020, COVID-19 has spread to 216 countries and territories. Severe infection of SARS-CoV-2 cause extreme increase in inflammatory chemokines and cytokines that may lead to multi-organ damage and respiratory failure. Currently, no specific treatment and authorized vaccines are available for its treatment. Renin angiotensin system holds a promising role in human physiological system specifically in regulation of blood pressure and electrolyte and fluid balance. SARS-CoV-2 interacts with Renin angiotensin system by utilizing angiotensin-converting enzyme 2 (ACE2) as a receptor for its cellular entry. This interaction hampers the protective action of ACE2 in the cells and causes injuries to organs due to persistent angiotensin II (Ang-II) level. Patients with certain comorbidities like hypertension, diabetes, and cardiovascular disease are under the high risk of COVID-19 infection and mortality. Moreover, evidence obtained from several reports also suggests higher susceptibility of male patients for COVID-19 mortality and other acute viral infections compared to females. Analysis of severe acute respiratory syndrome coronavirus (SARS) and Middle East respiratory syndrome coronavirus (MERS) epidemiological data also indicate a gender-based preference in disease consequences. The current review addresses the possible mechanisms responsible for higher COVID-19 mortality among male patients. The major underlying aspects that was looked into includes smoking, genetic factors, and the impact of reproductive hormones on immune systems and inflammatory responses. Detailed investigations of this gender disparity could provide insight into the development of patient tailored therapeutic approach which would be helpful in improving the poor outcomes of COVID-19. Graphical abstract.


Subject(s)
COVID-19/epidemiology , Cardiovascular Diseases/epidemiology , Hypertension/epidemiology , SARS-CoV-2/pathogenicity , Angiotensin-Converting Enzyme 2/genetics , COVID-19/complications , COVID-19/genetics , COVID-19/virology , Cardiovascular Diseases/complications , Cardiovascular Diseases/genetics , Cardiovascular Diseases/virology , Diabetes Mellitus/epidemiology , Diabetes Mellitus/genetics , Diabetes Mellitus/virology , Female , Humans , Hypertension/complications , Hypertension/genetics , Hypertension/virology , Male , Renin-Angiotensin System/genetics , Sex Characteristics
6.
Indian J Surg ; 82(3): 295-296, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-591833
7.
Indian J Surg ; 82(3): 286-287, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-459234
8.
Int J Surg ; 79: 165-167, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-437477

ABSTRACT

Coronavirus Disease 2019(COVID 19) had emerged as a global pandemic in recent times. The healthcare sector is at the epicentre of this unprecedented global pandemic challenge. Hospitals all over the world have reduced the number of non-emergency surgeries in order to utilise the staff and resources in a more efficient way. Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is most transmitted via respiratory droplets, but risk of transmission is hugely increased while doing aerosol generating procedures (AGPs). Laparoscopy remains the preferred surgical approach for most surgical indications. There is theoretical possibility of generation of aerosols contaminated with COVID-19 from leaked CO2 and smoke generation after energy device use. The aim of this paper is to review available evidence evaluating the risk of spread of COVID-19 during necessary laparoscopic procedures and to compile guidelines from relevant professional organizations to minimize this risk.


Subject(s)
Coronavirus Infections/transmission , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Laparoscopy , Pandemics , Pneumonia, Viral/transmission , Aerosols , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Humans , India/epidemiology , Infection Control , Laparoscopy/methods , Pneumonia, Viral/epidemiology , Practice Guidelines as Topic , SARS-CoV-2 , Surgeons
9.
Indian J Surg ; 82(3): 281, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-361340
SELECTION OF CITATIONS
SEARCH DETAIL